[1] 张武霞,庄志彬,郭淑珍,等.特异性促炎症消退介质结构与功能研究进展[J]. 免疫学杂志,2020,36(5):432-441.
[2] CHIANG N, SERHAN CN. Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors. Mol Aspects Med. 2017;58:114-129.
[3] HAAS-STAPLETON EJ, YAN L, SONG H, et al. Candida albicans modulates host defense by biosynthesizing the pro-resolving mediator resolvin E1. PLoS ONE. 2017;2(12):e1316.
[4] BALTA MG, LOOS BG, NICU EA. Emerging Concepts in the Resolution of Periodontal Inflammation: A Role for Resolvin E1. Front Immunol. 2017;8:1682.
[5] DUVALL MG, LEVY BD. DHA-and EPA-derived resolvins, protectins, and maresins in airway inflammation. Eur J Pharmacol. 2016;785:144-155.
[6] CIANCI E, RECCHIUTI A, TRUBIANI O, et al. Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins. Stem Cells Transl Med. 2016;5(1):20-32.
[7] FREDMAN G, SERHAN CN. Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution. Biochem J. 2011;437(2):185-197.
[8] XU H, CHEN J, GE J, et al. Resolvin E1 Ameliorates Pulpitis by Suppressing Dental Pulp Fibroblast Activation in a Chemerin Receptor 23-dependent Manner. J Endod. 2019;45(9):1126-1134.e1.
[9] 徐华兴,张琪. 消退素在炎症消退中的研究进展及其在牙髓炎症调控中的应用[J]. 口腔医学,2018,38(8):743-746.
[10] CHATTOPADHYAY R, RAGHAVAN S, RAO GN. Resolvin D1 via prevention of ROS-mediated SHP2 inactivation protects endothelial adherens junction integrity and barrier function. Redox Biol. 2017;12:438-455.
[11] GYURKO R, VAN DYKE TE. The role of polyunsaturated omega-3 fatty acid eicosapentaenoic acid-derived resolvin E1 (RvE1) in bone preservation. Crit Rev Immunol. 2014;34(4):347-357.
[12] EL KHOLY K, FREIRE M, CHEN T, et al. Resolvin E1 Promotes Bone Preservation Under Inflammatory Conditions. Front Immunol. 2018;9:1300.
[13] SAITO T, HASEGAWA-MORIYAMA M, KURIMOTO T, et al. Resolution of Inflammation by Resolvin D1 Is Essential for Peroxisome Proliferator-activated Receptor-gamma-mediated Analgesia during Postincisional Pain Development in Type 2 Diabetes. Anesthesiology. 2015;123(6):1420-1434.
[14] O YY, LEE JY, PARK CK. Resolvin E1 Inhibits Substance P-Induced Potentiation of TRPV1 in Primary Sensory Neurons. Mediators Inflamm. 2016;2016: 5259321.
[15] MEESAWATSOM P, BURSTON J, HATHWAY G, et al. Inhibitory effects of aspirin-triggered resolvin D1 on spinal nociceptive processing in rat pain models. J Neuroinflammation. 2016;13(1):233.
[16] ZHANG LY, LIU ZH, ZHU Q, et al. Resolvin D2 Relieving Radicular Pain is Associated with Regulation of Inflammatory Mediators, Akt/GSK-3beta Signal Pathway and GPR18. Neurochem Res. 2018;43(12):2384-2392.
[17] FREIRE MO, DALLI J, SERHAN CN, et al. Neutrophil Resolvin E1 Receptor Expression and Function in Type 2 Diabetes. J Immunol. 2017;198(2): 718-728.
[18] SIMA C, MONTERO E, NGUYEN D, et al. ERV1 Overexpression in Myeloid Cells Protects against High Fat Diet Induced Obesity and Glucose Intolerance. Sci Rep. 2017;7(1):12848.
[19] SIMA C, PASTER B, VAN DYKE TE. Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes. Crit Rev Immunol. 2018;38(5):343-365.
[20] HASTURK H, ABDALLAH R, KANTARCI A, et al. Resolvin E1 (RvE1) Attenuates Atherosclerotic Plaque Formation in Diet and Inflammation-Induced Atherogenesis. Arterioscler Thromb Vasc Biol. 2015;35(5):1123-1133.
[21] ROSSI S, DI FILIPPO C, GESUALDO C, et al. Protection from endotoxic uveitis by intravitreal Resolvin D1: involvement of lymphocytes, miRNAs, ubiquitin-proteasome, and M1/M2 macrophages. Mediators Inflamm. 2015:149381.
[22] MAISTO R, TROTTA MC, PETRILLO F, et al. Resolvin D1 Modulates the Intracellular VEGF-Related miRNAs of Retinal Photoreceptors Challenged With High Glucose. Front Pharmacol. 2020;11:235.
[23] TROTTA MC, PIERETTI G, PETRILLO F, et al. Resolvin D1 reduces mitochondrial damage to photoreceptors of primary retinal cells exposed to high glucose. J Cell Physiol. 2020;235(5):4256-4267.
[24] NELSON JW, LEIGH NJ, MELLAS RE, et al. ALX/FPR2 receptor for RvD1 is expressed and functional in salivary glands. Am J Physiol Cell Physiol. 2014; 306(2):C178-C185.
[25] WANG CS, WEE Y, YANG CH, et al. ALX/FPR2 Modulates Anti-Inflammatory Responses in Mouse Submandibular Gland. Sci Rep. 2016;6:24244.
[26] RUSSELL CD, SCHWARZE J. The role of pro-resolution lipid mediators in infectious disease. Immunology. 2014;141(2):166-173.
[27] DONDONI L, SCARPARO RK, KANTARCI A, et al. Effect of the pro-resolution lipid mediator Resolvin E1 (RvE1) on pulp tissues exposed to the oral environment. Int Endod J. 2014;47(9):827-834.
[28] SSCARPARO R K, DONDONI L, BOTTCHER DE, et al. Intracanal delivery of Resolvin E1 controls inflammation in necrotic immature rat teeth. J Endod. 2014;40(5):678-682.
[29] SIDDIQUI YD, OMORI K, ITO T, et al. Resolvin D2 Induces Resolution of Periapical Inflammation and Promotes Healing of Periapical Lesions in Rat Periapical Periodontitis. Front Immunol. 2019;10:307.
[30] LEE CT, TELES R, KANTARCI A, et al. Resolvin E1 Reverses Experimental Periodontitis and Dysbiosis. J Immunol. 2016;197(7):2796-2806.
[31] 程抒华,徐华兴,陈杰,等. 消退素E1调控牙周膜成纤维细胞改善牙周组织炎症的研究[J]. 口腔生物医学,2019,10(2):68-72.
[32] MAEKAWA T, HOSUR K, ABE T, et al. Antagonistic effects of IL-17 and D-resolvins on endothelial Del-1 expression through a GSK-3beta-C/EBPbeta pathway. Nat Commun. 2015;6:8272.
[33] 唐彩金,曾启新,方梅飞.消退素D1治疗实验性大鼠牙周炎的研究[J]. 口腔医学研究,2017,33(12):1270-1273.
[34] 马飞,唐彩金,方梅飞,等. 消退素D1对牙周炎大鼠龈沟液中炎症因子影响的研究[J]. 实用口腔医学杂志,2018,34(5):610-613.
[35] 马飞,唐彩金,方梅飞,等. 消退素D1对牙周炎大鼠牙龈组织中IL-1β、IL-6表达的影响[J]. 牙体牙髓牙周病学杂志,2018,28(10):571-574+604.
[36] MIZRAJI G, HEYMAN O, VAN DYKE TE, et al. Resolvin D2 Restrains Th1 Immunity and Prevents Alveolar Bone Loss in Murine Periodontitis. Front Immunol. 2018;9:785.
[37] 马飞,唐彩金,曾启新. 消退素与牙周病关系的研究进展[J]. 牙体牙髓牙周病学杂志,2017,27(12):733-735+720.
[38] HERRERA BS, KANTARCI A, ZARROUGH A, et al. LXA4 actions direct fibroblast function and wound closure. Biochem Biophys Res Commun. 2015;464(4): 1072-1077.
[39] RREY C, NADJAR A, BUAUD B, et al. Resolvin D1 and E1 promote resolution of inflammation in microglial cells in vitro. Brain Behav Immun. 2016;55:249-259.
[40] ZHAO YL, ZHANG L, YANG YY, et al. Resolvin D1 Protects Lipopolysaccharide-induced Acute Kidney Injury by Down-regulating Nuclear Factor-kappa B Signal and Inhibiting Apoptosis. Chin Med J (Engl). 2016;129(9):1100-1107.
[41] GAO Y, ZHANG H, LUO L, et al. Resolvin D1 Improves the Resolution of Inflammation via Activating NF-kappaB p50/p50-Mediated Cyclooxygenase-2 Expression in Acute Respiratory Distress Syndrome. J Immunol. 2017;199(6):2043-2054.
[42] ZHONG X, LEE HN, SURH YJ. RvD1 inhibits TNFalpha-induced c-Myc expression in normal intestinal epithelial cells and destabilizes hyper-expressed c-Myc in colon cancer cells. Biochem Biophys Res Commun. 2018;496(2):316-323.
[43] 石哲玮,刘胜新,张银宇,等. Resolvin D2通过抑制NF-κB通路减轻病毒性心肌炎小鼠炎症反应的研究[J]. 心电与循环,2020,39(1):35-40.
[44] CHUN HW, LEE J, PHAM TH, et al. Resolvin D5, a Lipid Mediator, Inhibits Production of Interleukin-6 and CCL5 Via the ERK-NF-kappaB Signaling Pathway in Lipopolysaccharide-Stimulated THP-1 Cells. J Microbiol Biotechnol. 2020;30(1):85-92.
[45] CROASDELL A, THATCHER TH, KOTTMANN RM, et al. Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages. Am J Physiol Lung Cell Mol Physiol. 2015;309(8):L888-L901.
[46] XU J, DUAN X, HU F, et al. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-kappaB pathways. J Dermatol Sci. 2018;89(2):127-135.
[47] LU Y, XU Q, YIN G, et al. Resolvin D1 inhibits the proliferation of lipopolysaccharide- treated HepG2 hepatoblastoma and PLC/PRF/5 hepatocellular carcinoma cells by targeting the MAPK pathway. Exp Ther Med. 2018;16(4):3603-3610.
[48] JUNG TW, HWANG HJ, HONG HC, et al. Resolvin D1 reduces ER stress-induced apoptosis and triglyceride accumulation through JNK pathway in HepG2 cells. Mol Cell Endocrinol. 2014;391(1-2):30-40.
[49] COX R JR, PHILLIPS O, FUKUMOTO J, et al. Resolvins Decrease Oxidative Stress Mediated Macrophage and Epithelial Cell Interaction through Decreased Cytokine Secretion. PLoS One. 2015;10(8):e0136755.
[50] ZUO G, ZHANG D, MU R, et al. Resolvin D2 protects against cerebral ischemia/reperfusion injury in rats. Mol Brain. 2018;11(1):9.
[51] BATHINA S, GUNDALA NKV, RHENGHACHAR P, et al. Resolvin D1 Ameliorates Nicotinamide-streptozotocin-induced Type 2 Diabetes Mellitus by its Anti-inflammatory Action and Modulating PI3K/Akt/mTOR Pathway in the Brain. Arch Med Res. 2020;51(6):492-503.
[52] XIE W, WANG H, LIU Q, et al. ResolvinD1 reduces apoptosis and inflammation in primary human alveolar epithelial type 2 cells. Lab Invest. 2016;96(5):526-536.
[53] DEYAMA S, SHIMODA K, SUZUKI H, et al. Resolvin E1/E2 ameliorate lipopolysaccharide-induced depression-like behaviors via ChemR23. Psychopharmacology (Berl). 2018;235(1):329-336.
[54] Deyama S, Ishikawa Y, Yoshikawa K, et al. Resolvin D1 and D2 Reverse Lipopolysaccharide-Induced Depression-Like Behaviors Through the mTORC1 Signaling Pathway. Int J Neuropsychopharmacol. 2017;20(7):575-584.
[55] LIU Y, YUAN X, LI W, et al. Aspirin-triggered resolvin D1 inhibits TGF-beta1-induced EMT through the inhibition of the mTOR pathway by reducing the expression of PKM2 and is closely linked to oxidative stress. Int J Mol Med. 2016;38(4):1235-1242.
[56] LI L, WU Y, WANG Y, et al. Resolvin D1 promotes the interleukin-4-induced alternative activation in BV-2 microglial cells. Neuroinflammation. 2014;11:72.
[57] RAJASAGI NK, BHELA S, VARANASI SK, et al. Frontline Science: Aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology. J Leukoc Biol. 2017;102(5):1159-1171.
[58] BAI X, SHAO J, ZHOU S, et al. Inhibition of lung cancer growth and metastasis by DHA and its metabolite, RvD1, through miR-138-5p/FOXC1 pathway. J Exp Clin Cancer Res. 2019;38(1):479.
[59] XIA H, WANG J, SUN S, et al. Resolvin D1 Alleviates Ventilator-Induced Lung Injury in Mice by Activating PPARgamma/NF-kappaB Signaling Pathway. Biomed Res Int. 2019;2019:6254587.
[60] LIU W, HUANG J, DOYCHEVA D, et al. RvD1 binding with FPR2 attenuates inflammation via Rac1/NOX2 pathway after neonatal hypoxic-ischemic injury in rats. Exp Neurol. 2019;320:112982.
[61] KANG JW, CHOI HS, SHIN JK, et al. Resolvin D1 activates the sphingosine-1-phosphate signaling pathway in murine livers with ischemia/reperfusion injury. Biochem Biophys Res Commun. 2019;514(4):1058-1065.
[62] SUN L, WANG Y, WANG L, et al. Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP. J Exp Clin Cancer Res. 2019;38(1):170.
[63] ZHUO Y, ZHANG S, LI C, et al. Resolvin D1 Promotes SIRT1 Expression to Counteract the Activation of STAT3 and NF-kappaB in Mice with Septic-Associated Lung Injury. Inflammation. 2018;41(5):1762-1771.
[64] ZHANG Z, HU X, QI X, et al. Resolvin D1 promotes corneal epithelial wound healing and restoration of mechanical sensation in diabetic mice. Mol Vis. 2018;24:274-285.
[65] POSSO SV, QUESNOT N, MORAES JA, et al. AT-RVD1 repairs mouse lung after cigarette smoke-induced emphysema via downregulation of oxidative stress by NRF2/KEAP1 pathway. Int Immunopharmacol. 2018;56:330-338.
[66] MOTTOLA G, CHATTERJEE A, WU B, et al. Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway. PLoS One. 2017;12(3):e0174936.
[67] YAXIN W, SHANGLONG Y, HUAQING S, et al. Resolvin D1 attenuates lipopolysaccharide induced acute lung injury through CXCL-12/CXCR4 pathway. J Surg Res. 2014;188(1):213-221.
[68] YIN Y, CHEN F, WANG W, et al. Resolvin D1 inhibits inflammatory response in STZ-induced diabetic retinopathy rats: Possible involvement of NLRP3 inflammasome and NF-κB signaling pathway. Mol Vis. 2017;23:242-250.
[69] 方晨,梅咏玉,王晶,等. 消退素D1抑制NLRP3信号通路对DSS结肠炎小鼠的影响[J]. 中国药理学通报,2019,35(4):580-585.
|